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Inhibition of Retroviral Pathogenesis
by RNA Interference
protein complex, the RISC complex. The strands of the
siRNA are then believed to be unpaired, allowing the
message-complementary strand to bind to the targeted
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1Infectious Disease Laboratory mRNA and thereby program its degradation [1–4].
In plants and C. elegans, RNAi can also be amplified2 Gene Expression Laboratory
The Salk Institute for Biological Studies within cells in a pathway that is dependent on RNA-
dependent RNA polymerase (RdRP). According to cur-10010 North Torrey Pines Road
La Jolla, California 92037 rent models, RdRP extends RNA synthesis along the
target message by using the antisense siRNA strand as
a primer. The extended duplex RNA is then cleaved into
further siRNAs, resulting in amplification of RNAi within aSummary
cell. In plants and worms, RNAi also can spread between
cells of a tissue or organism [1, 3, 4]. Remarkably, RNAiBackground: RNA interference (RNAi) is a newly discov-
can even be transmitted through the germline [14].ered cellular defense system that is known to suppress
RNAi has been demonstrated to act as an antiviralreplication of genomic parasites in model organisms. It
system in plants. Mutations in genes encoding the com-has been widely conjectured that RNAi may also serve
ponents of the RNAi system cause cells to become moreas an antiviral system in vertebrates.
sensitive to infection by some plant viruses, and severalResults: Retroviral infection could be initiated by elec-
plant viruses have been found to encode inhibitors oftroporation of cloned Rous sarcoma virus (RSV) proviral
RNAi [11, 15–17]. The possible activity of RNAi againstDNA into the developing chick neural tube. Coelectro-
vertebrate genomic parasites has not previously beenporation of proviral DNA and short double-stranded
reported.RNAs matching sequences of avain retroviruses, which
We have developed a convenient system for testingwere designed to induce RNAi against RSV, inhibited
RNAi in vertebrates using electroporation of chick em-viral replication. Replication of RSV after electroporation
bryos. Nucleic acids are injected into the neural tube 2resulted in disruption of embryonic development and
days after fertilization, then a current is applied in anearly death, but this, too, could be suppressed by RNAi
orthogonal direction. This introduces nucleic acid intoagainst the RSV genome. RNAi could also inhibit the
cells near the positive electrode [18]. In initial experi-growth of RSV and HIV in cell culture. Analysis of the
ments, we demonstrated that siRNAs against the genestep of the retroviral life cycle that is inhibited by RNAi
for green fluorescent protein (gfp) could inhibit expres-revealed that it primarily prevented accumulation of the
sion of GFP. We then tested whether RNAi could inhibitviral RNAs synthesized late during infection. RNA ge-
the replication of a nonpathogenic derivative of Rousnomes introduced in viral particles early during infection
sarcoma virus (RSV). Plasmid DNAs encoding the RSVwere less sensitive.
genome were electroporated into embryos along withConclusions: RNAi can block retroviral infection in ver-
siRNAs against RSV or control siRNAs, and this allowedtebrates. The tissue electroporation method described
for the demonstration of RNAi-mediated control of RSVhere should allow RNAi to be used widely to study gene
infection. Electroporation of pathogenic RSV resulted infunction and control of infection in vertebrate animals.
disruption of the neural tube and death of embryos, but
this could be reversed by coelectroporation of RNAi.
Introduction These data raised the possibility that RNAi may be capa-
ble of inhibiting other retroviruses such as HIV. To test
Double-stranded RNA can program the selective degra- this, we characterized RNAi against HIV and RSV in cell
dation of sequence-matched RNAs in cells, a process culture models. Viral RNA genomes just entering cells
named RNA interference (RNAi) (for recent reviews, see were insensitive to RNAi, but, late during infection, the
[1–4]). RNAi was first discovered in plants, worms, and viral genomes were efficiently degraded. Together these
other model organisms, but more recently RNAi has data establish that the RNAi system can control the
been reported in vertebrate cells as well [5–10]. In model replication of retroviruses and begin to specify the inhib-
organisms, RNAi has been shown to selectively block itory mechanism.
the replication of genomic parasites such as viruses or
transposons [11–13]. Here, we investigate whether RNAi
can be directed to inhibit replication of retroviruses in Results
vertebrates.
Genetic and biochemical studies of RNAi have led to a RNAi Activity in Chick Embryos
model for its action. Double-stranded RNA, presumably We have used electroporation of chick embryos to eval-
transcribed from DNA of a genomic parasite, is initially uate the activity of RNAi against avian retroviruses. Short
cleaved into 21- to 23-base pair small interfering RNAs 21- to 23-bp double-stranded siRNAs were designed as
(siRNAs). These siRNAs are then recruited into a nucleo- described in [19] and were synthesized chemically. In
initial studies, we introduced a plasmid encoding gfp
into the chick neural tube at Hamburger and Hamilton3 Correspondence: bushman@salk.edu
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Figure 1. RNA Interference in Chick Embryos
(A–F) A plasmid encoding gfp (3 g/l, p156RRLsinPPTCMVGFPPRE, described in [35]) was pipetted into the neural tube of a 2-day-old chick
embryo together with the indicated siRNA. Nucleic acids were introduced into tissue proximal to the positive electrode by electroporation
essentially as described [21]. Embryos (day 4 postfertilization) are shown in (A)–(C), and the fluorescence signal is shown in (D)–(F) (“GFP in
whole embryo”).
(G–I) Present transverse sections through the spinal cord. The GFP signal is green. Tissue was stained with an antibody against Isl1/2 to
reveal motor neurons (red); note that the DRG is a segmental structure and so does not appear in every section. The plus and minus signs
indicate the positive and negative electrodes.
(J) GFP signal intensity was quantitated with ImageQuant. The electroporated () and nonelectroporated () halves of the neural tube are
compared.
(H.H.) stage 11 (approximately E2, [20]) together with proximal to the positive electrode and occasionally into
neural crest cells that migrate from the neural tube andsiRNA against gfp (siGFP). As a control, siRNAs against
irrelevant sequences were also tested to document the differentiate into structures such as sensory neurons of
the dorsal root ganglion (DRG) [21].specificity (an assay with siLUC, against firefly luciferase
RNA, is shown). Tissue electroporation efficiently intro- Two days after electroporation, embryos were ana-
lyzed by whole-mount fluorescence microscopy (Fig-duced the nucleic acids into the half of the neural tube
RNAi against Retroviruses In Vivo
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Figure 2. Inhibition of RSV Replication by RNA Interference
(A–C) Embryos were electroporated with a cloned RSV genome (RCASBP[B], [22]), and the siRNA is indicated at the top of the figure at day
2 postfertilization. At day 4, embryos were harvested, sectioned transversely through the spinal cord, and stained with an RSV Gag antibody.
Gag-positive staining is shown in red. Spreading infection is seen with the control (A) siLUC RNA, but not with (B) siRSV-gag-1 or (C) siRSV-
gag-2.
(D) Images were quantitated with ImageQuant; the electroporated () and nonelectroporated () halves of the neural tube (nt) are compared
with the adjoining mesenchyme (m).
ures 1A–1F). Extensive fluorescence was seen in the due to the addition of RNAi up to a concentration of
3 g/l, and motor neuron differentiation proceededneural tube of the control siLUC-treated embryos (Fig-
ures 1A and 1D) and in embryos electroporated with the normally, as monitored by antibody staining for Isl1/2.
These data indicate that the chick neural tube containsgfp plasmid only (data not shown). Treatment with 1.5
g/l siGFP, in contrast, greatly abrogated the fluores- the machinery for RNAi and that RNAi can be elicited
without toxicity by tissue electroporation of siRNAs.cent signal (Figures 1B and 1E). Treatment with lower
doses of siGFP (0.5 g/l) resulted in weaker inhibition
(Figures 1C and 1F). Treatment with either RNA strand Control of RSV Infection by RNAi
We next investigated whether RNAi could inhibit retrovi-alone did not inhibit the appearance of the fluorescent
signal, indicating that the RNAs are not working by an ral replication. As a model virus, we used RCASBP(B),
which is a derivative of RSV modified for use as a retro-antisense mechanism (data not shown). Embryos were
then sectioned through the spinal cord, and GFP expres- viral vector by removal of the src oncogene [22].
RCASBP(B) was chosen because it is known to be com-sion was assayed by fluorescence microscopy (Figures
1G–1I, green signal). The intensity of GFP fluorescence petent for replication in the chick neural tube. Embryos
were electroporated with a plasmid encoding theis quantitated in Figure 1J. An intense GFP signal is
seen in the electroporated half of the embryo, and the RCASBP(B) genome and either of two siRNAs against
RSV Gag (siRSV-gag-1 and siRSV-gag-2) or siLUC-1 assignal is reduced in a concentration-dependent fashion
by coelectroporation of siGFP. To visualize the tissue a nonspecific siRNA control. Electroporation was car-
ried out in embryos 2 days after fertilization and wasorganization and assess the specificity of RNAi, em-
bryos were also stained with an antibody recognizing analyzed at day 4 by sectioning and staining with an
antibody against RSV Gag.the endogenous nuclear proteins Isl1 and Isl2 expressed
by motor neurons and DRG (Isl1/2, Figures 1G–1I, red After treatment with the RCASBP(B) plasmid only (not
shown), or with RCASBP(B) and the siLUC-1 controlsignal). No increase in embryo mortality was observed
Figure 3. Inhibition of RSV Pathogenesis by RNAi
(A–F) Embryos were electroporated 2 days after fertilization with an RSV proviral DNA and the indicated siRNAs. A total of 36 hr later, the
embryos were sectioned and stained with antibodies recognizing the indicated proteins (mpm2, kip1, or gag; [A–F]). The mpm2 marker detects
tyrosine phosphorylation characteristic of mitosis, and kip1 detects the kip1 protein that inhibits cell cycle progression and so marks postmitotic
cells. (A, C, and E) No siRNA; (B, D, and F) siRSV-gag-2.
(G) Quantitation of abnormal cells stained with the mpm2 marker, comparing staining on the electroporated () and control () sides of the
embryo. Cells outside the normal axial zone of proliferation were summed over four slides. Note that the mpm2 marker detects cells in a
specific phase of the proliferative cycle and so stains relatively low numbers in any given section.
(H) Quantitation of cells stained with the kip1 marker, comparing staining on the electroporated () and control () sides of the neural tube.
Cells were counted in four sections for each bar graph.
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Figure 4. Inhibition of HIV-1 Replication by
RNAi
(A) A diagram of the assay for siRNA inhibition
of HIV-1 replication. HOS.T4.CXCR4 cells
were transfected with siRNAs and were then
infected with HIV-1 2 hr later. Two days later,
culture supernatants were harvested and ap-
plied to 5.25luc4 indicator cells. Integration
of HIV-1 cDNA followed by synthesis of Tat
protein activates the production of luciferase
and green fluorescent protein from the inte-
grated HIV-1 LTR-luc and LTR-gfp reporter
genes.
(B) Inhibition of HIV replication assayed with
the LTR-luc reporter. All values were normal-
ized to the no siRNA sample. “ss” indicates
sense strand only of the siRNA, “as” indicates
antisense strand only, and “ds” indicates the
complete double-stranded siRNA. siHIV-1
matches HIV gag, siHIV-2 matches HIV pol,
and siMLV matches Moloney murine leuke-
mia virus gag and is active against MLV in
cell culture (data not shown).
RNA (Figure 2A), Gag staining could be seen in one half inhibit viral replication (data not shown). These findings
indicate that RNAi can suppress RSV replication effi-of the spinal cord (red signal). The lumen of the neural
tube and the unilateral electroporation method re- ciently in chick embryos.
stricted the infection to one half of the cord; however,
the replication-competent virus did spread into the sur- Inhibition of RSV Pathogenesis by RNAi
We next investigated whether RNAi could inhibit patho-rounding mesenchyme due to secondary cell infection.
After electroporation of the RSV genome with either genesis by RSV in the chick embryo model. RSV was
electroporated into 2-day-old embryos, and the effectsof the siRSVs, infection was only evident in a few cells
(Figures 2B and 2C), indicating efficient inhibition of viral were assessed after another 3 days of incubation. All
embryos electroporated with RSV only or RSV plus con-replication. Much less viral spread was evident at the
time point shown (2 days postelectroporation). There trol siRNA were dead by this time (16/16 and 12/12
assayed, respectively). In contrast, 7/12 embryoswas little virus evident in the nonelectroporated half of
the neural tube, apparently because the lumen of the treated with siRSV-gag-2 survived, indicating inhibition
of the lethal effect by RNAi.tube and surrounding membranes formed a barrier to
viral spread. Quantitation of the intensity of the Gag To assay pathogenesis in more detail, embryos were
sectioned 36 hr after infection and were stained withsignal (Figure 2D) suggested that siRSV-gag-2 is a
somewhat more effective inhibitor than siRSV-gag-1. markers for mitotic cells (mpm2), nonproliferative cells
(kip1), and RSV Gag (Figure 3). In the absence of specificElectroporation of single strands of the siRNAs did not
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Figure 7. RNAi Does Not Act Early against Incoming Viral RNA Ge-
nomes
The HIV-1 cDNA copy number in HOS.T4.CXCR4 cells was assayed
after infection with HIV R9. Cells were transfected with the indicated
siRNA and were then infected with HIV 2 hr later. A total of 12 hr
after that, DNA was harvested and the total HIV-1 cDNA genomes
were quantified by fluorescence-monitored PCR as described [24].
The PCR primers that were used required that the second jump of
reverse transcription be completed for amplification to take place.
Figure 6. RNAi Inhibits Viral RNA Accumulation
RNAs produced in control and siRNA-treated cells were assayed
bated for 3 days to allow virus production. Virus in cul-by Northern blotting. HOS.T4.CXCR4 cells were transfected with
ture supernatants was then quantified by infection ofpR9 and the indicated siRNAs. Two days later, total RNA was har-
5.25luc4 indicator cells, which contain LTR-luc and LTR-vested, separated by electrophoresis, and probed with a fragment
of pR9 complementary to the integrase region. gfp reporters that are activated by Tat protein supplied
by an integrated HIV provirus (Figure 4A, N. Landau,
personal communication). Thus, assay of luciferase or
siRNA, the neural tube was disorganized, with mis- GFP provides a quantitative measure of virus produc-
placed proliferative cells and abnormal masses of non- tion. As a control, a nonspecific siRNA was compared
proliferative cells evident (Figures 3A, 3C, and 3E). In with siHIV-gag and siHIV-pol for inhibition of HIV-1 infec-
the presence of siRSV-gag-2, the embryos were indistin- tion. The controls shown used siRNAs matching se-
guishable from embryos that were not infected with RSV quences from Moloney murine leukemia virus (MLV), but
(Figures 3B, 3D, and 3F; quantitated in 3G and 3H, and similar data were obtained with several other nonspe-
data not shown). These data confirm that RSV causes cific siRNAs (not shown).
abnormal proliferation and tissue disorganization in em- HIV-1 production was inhibited 90% by siHIV-gag
bryos, and this effect can be reversed with RNAi. or siHIV-pol, as assayed by the LTR-luc reporter (Figure
4B). siMLV-gag-2, which inhibits MLV replication (data
not shown), was not inhibitory. Each of the siHIV-gagRNAi Inhibits Accumulation of Retroviral mRNAs
but Does Not Attack Incoming Viral Genomes or siHIV-pol RNA strands tested alone showed no inhibi-
tion. The effect of siRNA could also be monitored byWe next asked which step(s) in the viral life cycle were
interrupted by RNAi. Initially, we used HIV as a model assaying the LTR-gfp reporter in 5.25luc4 indicator cells
or by assaying the accumulation of HIV-1 p24 capsiddue to its clinical importance and the availability of effi-
cient assays to dissect the viral life cycle. siRNAs were antigen in the supernatant of infected HOS.T4.CXCR4
cells. In both cases, strong inhibition was seen by thedesigned against sequences in the HIV-1 gag (siHIV-
gag) or integrase (siHIV-pol) regions. To test for RNAi specific siRNAs, but not by the control siRNAs (data not
shown; see below).inhibition of HIV-1 replication, HOS.T4.CXCR4 cells [23]
were transfected with siRNAs and were then infected We next used this system to determine the step in
HIV replication that is affected by the siRNAs. Inhibitionwith HIV-1 (Figure 4A). Cells were washed, then incu-
Figure 5. RNAi Blocks Retroviral Gene Expression Late during Infection
(A) Cotransfection of siRNAs and HIV-1-encoding plasmids into HOS.T4.CXCR4 cells, followed by an assay of virus output with 5.25luc4
indicator cells (luc marker). Two different HIV-encoding plasmids were tested, pNL4-3 and pR9. The nonspecific siRNAs tested include siGFP-1
(not shown) and siMLV-1 and siMLV-2, which also had no effect (shown). Values were normalized to the no siRNA control.
(B) The effects of cotransfection of siRNAs and HIV-1-encoding plasmids revealed by activation of the LTR-gfp reporter in 5.25luc4 indicator
cells.
(C) Output of HIV-1 from infected HOS.T4.CXCR4 cells scored by quantitating HIV-1 p24 (capsid antigen) in the culture supernatant. “Control”
indicates no virus in the initial infection.
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and 5B) or by quantifying p24 capsid production (Figure
5C). siRNAs against HIV-1 were highly inhibitory in this
setting (95%), while control siRNAs (siMLV-gag-1 and
siMLV-gag-2) did not inhibit virus production. Analysis
by Northern blot revealed that siHIV-1 and siHIV-2 spe-
cifically reduced accumulation of the viral genomic RNA
(Figure 6).
To assay the effect of siRNA on the early steps of
infection, HOS.T4.CXCR4 cells were infected with HIV-1
and the accumulation of reverse transcription products
was quantified. Efficient reverse transcription requires
an intact RNA template, so possible action of RNAi
should result in reduced accumulation of viral cDNA.
DNA samples were harvested from cells 12 hr after infec-
tion, a time at which reverse transcription products are
known to peak in abundance [24]. Viral cDNA copies
were quantified by fluorescence-monitored quantitative
PCR with primers that require the two template transfers
of reverse transcription to be completed for the ampli-
con to be produced [24]. No significant differences were
detected between siRNA-treated and nontreated cells,
and this reveals that viral RNA genomes packaged in
early replication complexes were not efficient substrates
for RNAi (Figure 7). Thus, RNAi was active against
mRNAs transcribed late during infection from proviral
DNA but did not attack RNA genomes early after entry.
Inhibition of the late steps of RSV replication by RNAi
was also tested (Figure 8A). Chicken DF-1 cells were
transfected with siRSV-gag-1, siRSV-gag-2, or nonspe-
cific siRNAs, and then infection was initiated by trans-
fection with a plasmid encoding RCASBP(B). Two days
later, RSV particles were harvested from cell superna-
tants and were analyzed by Western blot for accumula-
tion of RSV capsid proteins. siRSV-gag-1 and siRSV-
gag-2 showed inhibition in both settings. The single
strands of siRSV-1 or siRSV-2 were not inhibitory (Figure
8). Inhibition of RSV replication by RNAi could also be
documented in experiments in which RSV genomes
were introduced by infection rather than transfection
(data not shown).
To assess the effects of siRSV on the early steps of
infection, DF-1 cells were treated with siRSV-gag-2 or
siHIV-gag as a control and were infected withFigure 8. RNAi Inhibits RCASBP(B) by Blocking Late Accumulation
RCASBP(B), and reverse transcription was measured 12of Viral Proteins but Not by Degrading Incoming Viral Genomes
hr later (Figure 8B). As with HIV, there was no significant(A) Inhibition of RSV production by RNAi. RCASBP(B) genomes were
transfected into DF-1 cells along with the indicated siRNAs. A total inhibition of cDNA accumulation by specific siRNAs.
of 48 hr later, culture supernatants were harvested, virions were These data indicate that RNAi acts primarily on RSV
recovered by centrifugation, and viral proteins were quantified by messages produced late during infection and, together
a Western blot probed with an anti-RSV p19 antibody. with data on HIV, suggests that this may be generally
(B) RNAi does not inhibit the accumulation of viral cDNA early after
true of retroviruses.infection. DF-1 cells were infected with RCASBP(B), then total DNA
was harvested 12 hr later. The number of viral genomes was quanti-
Discussiontated by using real-time PCR (Taqman).
Here, we report that RNAi can act as an effective antiviral
of late viral transcription could be assayed by cotrans- system in vertebrates. We found that chick embryos
fecting siRNAs with a cloned HIV-1 provirus. Introducing supported efficient RNAi using in ovo electroporation
the HIV genome in this way bypasses the early steps of to introduce nucleic acids. RNAi targeted against RSV
entry, reverse transcription, and integration and allows could inhibit retroviral replication and pathogenesis in
the effects on the late steps to be analyzed in isolation. this model, and RNAi could also block retroviral replica-
The effects on two different HIV-1-encoding plasmids tion in cell culture. These findings provide a convenient
were compared (pR9 and pNL4-3). Viral particles pro- vertebrate animal model for studies of RNAi, and they
duced from transfected HOS.T4.CXCR4 cells were ana- open a wide range of possibilities for the use of RNAi
against viral diseases.lyzed by infecting 5.25luc4 indicator cells (Figures 5A
RNAi against Retroviruses In Vivo
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Table 1. siRNAs Used in This Study
siRNA Sequence Target Gene nt Coordinates
siLUC-1 5-CUUACGCUGAGUACUUCGAAA-3 firefly luc 156–178
3-GUGAAUGCGACUCAUGAAGCU-5
siGFP-1 5-GCAAGCUGACCCUGAAGUUCAU-3 egfp 120–143
3-GCCGUUCGACUGGGACUUCAAG-5
siHIV-gag 5-GCAUUGGGACCAGGAGCGACA-3 HIV gag 1793–1815
3-UUCGUAACCCUGGUCCUCGCU-5 (NL4-3)
siHIV-pol 5-GGGGCAGUAGUAAUACAAGAU-3 HIV pol 4966–4988
3-UUCCCCGUCAUCAUUAUGUUC-5 (NL4-3)
siMLV-gag-1 5-UACUGGCCGUUCUCCUCUUTT-3 MLV gag 1033–1055
3-TTAUGACCGGCAAGAGGAGAA-5 (AF033811)
siMLV-gag-2 5-CCACCUAGUCCACUAUCGCTT-3 MLV gag 1338–1360
3-TTGGUGGAUCAGGUGAUAGCG-5 (AF033811)
siRSV-gag-1 5-GGGUUGCUUAUGUCUCCCUCA-3 RSV gag 478–500
3-UUCCCAACGAAUACAGAGGGA-5 (RCASBP[B])
siRSV-gag-2 5-CGCUAAACAGUGUAGGAAGCG-3 RSV gag 2007–2029
3-UUGCGAUUUGUCACAUCCUUC-5 (RCASBP[B])
RNAi in Chick Embryos in a RCAS vector. This thereby allows for spreading after
electroporation [6, 30].The chick embryo has served as a classical system for
studying the cellular interactions that control develop-
ment [20, 25, 26]. Though many tools are in place for RNAi against Eukaryotic Viruses
studying this system [27, 28], what has been lacking is We have surveyed siRNAs against four viruses, RSV,
the ability to inhibit gene expression. This paper pro- HIV, MLV, and adenovirus (this work and W.-Y.H., F.D.B.,
vides evidence that chick embryos, in particular the cells and M. Weitzman, unpublished data), and found that
in the developing neural tube that give rise to the spinal each could be specifically inhibited, suggesting that
cord, contain the machinery to use siRNAs as a sub- RNAi will be widely effective at inhibiting viral replication.
strate for the targeted degradation of mRNAs. In this As yet, no vertebrate virus has been reported to be
study, electroporation with siRNAs did not block devel- insensitive to RNAi. This is in contrast to plant viruses
opment by causing, for example, a general block to such as potyvirus and cucumber mosaic virus, which
translation via the interferon pathway. RNAi was spe- encode proteins that inhibit RNAi and permit escape of
cific, since endogenous genes Isl1/2 were not affected the antiviral effect [11, 15–17]. We note that the experi-
by the siRNAs tested and no other nonspecific effects ments reported here employed transfection of short
were seen. The methods described in this report offer double-stranded RNAs, so any viral-encoded inhibitors
great promise for studies of the neural tube, a powerful of earlier steps in the pathway would not have been
model for understanding how the nervous system is detected. It will be of great interest to determine whether
assembled [29]. It is now reasonable to expect that gene any such functions are present in eukaryotic viruses.
“knockdowns” can be performed in a tissue-specific It is as yet unclear whether any eukaryotic viruses
manner through targeted electroporations, that multiple produce double-stranded RNAs that can elicit RNAi dur-
genes can be targeted simultaneously by combining ing normal infection. Many viruses are inhibited by the
multiple siRNAs, and that the timing of the knockdown interferon response, which is activated in part by dou-
can be controlled by selecting the appropriate stage of ble-stranded RNA and suggests that double-stranded
development to introduce the siRNA. Optimal use of this RNA is produced in many viral infections. Double-
method would require inducing RNAi in a large fraction stranded RNA viruses would appear to be particularly
of the cells present. This may potentially be challenging at risk for activating RNAi. Further studies should soon
to achieve by electroporating siRNAs alone, but we note clarify the extent to which RNAi normally contributes to
that RNAi can be induced by suitably engineered DNA the control of viral infection in vertebrates.
hairpins that can be transcribed to yield double-
stranded RNA, and these may be delivered incorporated
Action of RNAi in the Viral Life Cycle
Studies reported here reveal that RNAi inhibited HIV-1
or RSV replication primarily by reducing accumulation
Table 2. DNA Oligonucleotides Used in This Study of viral messenger RNAs late during the infection cycle.
RNAi did not detectably degrade the genomic RNA ofPrimer Sequence (5 to 3)
HIV or RSV early after viral entry, as measured by quanti-
RSV-src-SalI GAGAGCGTCGACAGCACACAAGGTAGTT
fying late products of reverse transcription. Early duringRSV-src-ClaI CCATCGATGAAGCAGCGCAAAACGCCTAAC
infection, the incoming genomic RNA may be protectedHIV-F TGTGTGCCCGTCTGTTGTGT
by association with capsid, reverse transcriptase, andHIV-R GAGTCCTGCGTCGAGAGAGC
HIV-probe (FAM)-CAGTGGCGCCCGAACAGGGA-(TAMRA) other proteins associated with the viral core. Another
RSV-F CCCCGACGTGATAGTTAGGG possibility is that the incoming genomic RNA does not
RSV-R CGAGACGGATGGAGACAGGA traffic through a cellular compartment that is required
RSV-probe (FAM)-TCGGCCACAGACGGCGTGG-(TAMNph)
for association with the RNAi machinery. It has been
Current Biology
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GFP-transfected chick embryos were photographed with a Zeisssuggested that RNAi complexes may capture target
Stemi SV fluorescent dissecting scope.messages as they exit the nuclear pore or bind to the
ribosome (reviewed in [17]), so trafficking of early retrovi-
Cell Culture and siRNA Transfection
ral replication complexes may be unfavorable for engag- 293T, HOS.T4.CXCR4, and DF-1 cells were cultured in DMEM plus
ing RNAi. 10% fetal bovine serum (FBS). 5.25luc4 cells (which are CEMX174
cells transfected with LTR-gfp and LTR-luc reporters, a gift of N.
Landau) were cultured in RPMI medium plus 10% FBS. All mediaApplications of RNAi in Treating
also contained penicillin, streptomycin, and glutamine (1 PSG;Infectious Disease
GIBCO).The demonstration of RNAi activity against retroviral
LF2000 transfections were carried out as described in the manu-
pathogenesis suggests diverse possible applications in facture’s protocol (Invitrogen). A total of 1 l LF2000 was mixed
the prevention and therapy of disease. Practical applica- with 50 ml OMEM and incubated for 5 min at room temperature
before being added to 50 l OMEM containing 10 nM siRNA andtion of RNAi technology will be facilitated by the use of
0.5 g DNA. The 100 l mixture was then incubated for 20 min atengineered DNAs containing inverted repeat se-
room temperature. The siRNA-containing mixture was added to 5 quences, which can produce hairpin RNAs that are pro-
104–1  105 cells in DMEM (with FBS and without antibiotics) to acessed by the dicer nuclease to yield active siRNAs [6,
final volume of 0.6 ml in either 12- or 24-well plates. The mixture
30]. If such molecules are well tolerated by cells, it may was incubated for 2–4 hr, then the medium was replaced with 1–2
be possible to stably incorporate siRNA-producing DNA ml complete medium.
molecules in vertebrate cells to inhibit viral replication.
Retrovirus InfectionFarm animals might be engineered to resist economi-
HIV-1 stocks were generated by transfection of 293T cells by usingcally important infections. For example, several viral dis-
the LF2000 technique [37]. After 72 hr, supernatants were collectedeases of chickens might be targeted, including fowl pox,
and filtered through 0.45-m filters. Infections of siRNA-treated
chicken flu virus, and chicken anemia virus. Our finding HOS.T4.CXCR4 cells were carried out at a multiplicity of infection
that RNAi is highly active in chicken embryos suggests of 0.5–1 (180 ng p24 per 105 cells in 1 ml volume in a 12-well plate).
that it may be possible to block the replication of these After 12 hr, cells were washed and 2 ml media was added. 5.25luc4
indicator cells were infected with 0.2–0.5 ml viral supernatant in 24-viruses by introducing genes producing inhibitory
well plates (1 ml final volume per well).siRNAs into the chicken germline [31–33]. Many other
For analysis of RSV infection in DF-1 cells, cells were transfectedapplications in animal husbandry can be also envi-
with siRNA and RCASBP(B)-encoding DNA. A total of 48 hr after
sioned. infection, 1 ml viral supernatant was collected and centrifuged at
More speculatively, siRNA molecules might be used 14,000 rpm in an Eppendorf table top centrifuge for 1 hr at 4C,
directly to treat viral diseases in humans. A pivotal ques- then the supernatant was removed and the pellet was analyzed by
Western blot essentially as described [38]. Antibody against RSVtion in assessing the feasibility will be determining
Gag was obtained from the Developmental Studies Hybridoma Bankwhether RNAi amplifies within cells and spreads be-
(University of Iowa).tween cells in vertebrates, as has been reported in plants
and worms. The electroporation method described here
Quantitative PCR Assays of Viral cDNA Synthesis
should allow these key questions to be addressed in a The total DNA was purified at 12 hr after infection with the QIAGEN
vertebrate model. DNeasy kit and was suspended in 25 ng/l final concentration.
Quantitative PCR was carried out as described [24]. The primers
Experimental Procedures and probes used for quantitative PCR are listed in Table 2.
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